Viewing StudyNCT00267007



Ignite Creation Date: 2024-05-05 @ 12:09 PM
Last Modification Date: 2024-10-26 @ 9:21 AM
Study NCT ID: NCT00267007
Status: TERMINATED
Last Update Posted: 2014-06-04
First Post: 2005-12-16

Brief Title: A Study to Investigate the Neuroprotective Effect of PROCRIT Epoetin Alfa Versus Placebo in Cancer Patients Who Develop Chemotherapy-induced Peripheral Neuropathy
Sponsor: Johnson Johnson Pharmaceutical Research Development LLC
Organization: Johnson Johnson Pharmaceutical Research Development LLC

Conditions & Keywords Data

Conditions:
Name
Peripheral Neuropathy Chemotherapy-induced
Keywords:
Name View
Peripheral neuropathy View
Chemotherapy-induced View
Hemoglobin level View
Cancer View
Taxane View
Platinum-based chemotherapy View